Bedük Y - Search Results

1

Selection of patients for intravesical therapy for superficial bladder cancer.

Bedük Y, Yaman LS, Baltaci S, Müftüoğlu YZ, Yurdakul T, Göğüş O. Bedük Y, et al. Int Urol Nephrol. 1994;26(5):523-8. doi: 10.1007/BF02767653. Int Urol Nephrol. 1994. PMID: 7860199

2

The significance of random bladder biopsies in superficial bladder cancer.

Göğüş C, Bedük Y, Türkölmez K, Göğüs O. Göğüş C, et al. Among authors: beduk y. Int Urol Nephrol. 2002;34(1):59-61. doi: 10.1023/a:1021354811825. Int Urol Nephrol. 2002. PMID: 12549641

3

Thrombosis of the inferior vena cava by a testicular tumour.

Adsan O, Müftüoglu YZ, Süzer O, Bedük Y. Adsan O, et al. Among authors: beduk y. Int Urol Nephrol. 1995;27(2):179-82. doi: 10.1007/BF02551316. Int Urol Nephrol. 1995. PMID: 7591575

4

Evaluation of cellular immunity following bacillus Calmette-Guérin therapy in patients with superficial bladder cancer.

Sarica K, Baltaci S, Bedük Y, Süzer O, Kiliç S, Müftüğlu YZ, Göğüş O. Sarica K, et al. Among authors: beduk y. Urol Int. 1995;54(3):137-41. doi: 10.1159/000282707. Urol Int. 1995. PMID: 7604454

5

Evaluation of urinary glycosaminoglycan excretion in patients with renal cell carcinoma.

Sarica K, Türkölmez K, Soygür T, Ozer G, Yaman MO, Baltaci S, Bedük Y, Müftüoğlu YZ. Sarica K, et al. Among authors: beduk y. Eur Urol. 1997;31(1):54-7. doi: 10.1159/000474418. Eur Urol. 1997. PMID: 9032535

6

The efficacy of urinary cytology in the detection of recurrent bladder tumours.

Baltaci S, Süzer O, Ozer G, Bedük Y, Göğüş O. Baltaci S, et al. Among authors: beduk y. Int Urol Nephrol. 1996;28(5):649-53. doi: 10.1007/BF02552160. Int Urol Nephrol. 1996. PMID: 9061424 Clinical Trial.

7

Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma.

Soygür T, Bedük Y, Yaman O, Yilmaz E, Tokgöz G, Gögüş O. Soygür T, et al. Among authors: beduk y. Urology. 1999 Jan;53(1):88-91. doi: 10.1016/s0090-4295(98)00447-6. Urology. 1999. PMID: 9886594

8

Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma.

Baltaci S, Orhan D, Soyupek S, Bedük Y, Tulunay O, Gögüs O. Baltaci S, et al. Among authors: beduk y. J Urol. 2000 Jul;164(1):36-9. J Urol. 2000. PMID: 10840419

9

DNA ploidy and S-phase fraction as predictive factors of response and outcome following neoadjuvant methotrexate, vinblastine, epirubicin and cisplatin (M-VEC) chemotherapy for invasive bladder cancer.

Türkölmez K, Baltaci S, Bedük Y, Müftüoğlu YZ, Göğüş O. Türkölmez K, et al. Among authors: beduk y. Scand J Urol Nephrol. 2002 Feb;36(1):46-51. doi: 10.1080/003655902317259364. Scand J Urol Nephrol. 2002. PMID: 12002357

10

Combined interferon alpha with levamisole in patients with metastatic renal cell carcinoma.

Aksoy H, Baltaci S, Türkölmez K, Seçkiner I, Bedük Y. Aksoy H, et al. Among authors: beduk y. Int Urol Nephrol. 2001;33(3):457-9. doi: 10.1023/a:1019510628249. Int Urol Nephrol. 2001. PMID: 12230271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters